MDXH · MDxHealth SA
United States · RS rating 30 · As of 2026-10-14
| Price | 0.63 USD |
|---|---|
| 1-day change | -4.3% |
| RS rating (overall / 1M / 3M / 12M) | 30 / 33 / 96 / 5 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 19 / 12 / 4 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -6.2% |
| Sales growth Q/Q | +7.7% |
| Distance from 52-week high | +87.4% |
| Market cap (USD) | $111.5M |